Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Integration of machine learning and mechanistic models accurately predicts variation in cell density of glioblastoma using multiparametric MRI.

Gaw N, Hawkins-Daarud A, Hu LS, Yoon H, Wang L, Xu Y, Jackson PR, Singleton KW, Baxter LC, Eschbacher J, Gonzales A, Nespodzany A, Smith K, Nakaji P, Mitchell JR, Wu T, Swanson KR, Li J.

Sci Rep. 2019 Jul 11;9(1):10063. doi: 10.1038/s41598-019-46296-4.

PMID:
31296889
Free Article
2.

Improved model prediction of glioma growth utilizing tissue-specific boundary effects.

Jacobs J, Rockne RC, Hawkins-Daarud AJ, Jackson PR, Johnston SK, Kinahan P, Swanson KR.

Math Biosci. 2019 Jun;312:59-66. doi: 10.1016/j.mbs.2019.04.004. Epub 2019 Apr 19.

PMID:
31009624
3.

The 2019 mathematical oncology roadmap.

Rockne RC, Hawkins-Daarud A, Swanson KR, Sluka JP, Glazier JA, Macklin P, Hormuth DA, Jarrett AM, Lima EABF, Tinsley Oden J, Biros G, Yankeelov TE, Curtius K, Al Bakir I, Wodarz D, Komarova N, Aparicio L, Bordyuh M, Rabadan R, Finley SD, Enderling H, Caudell J, Moros EG, Anderson ARA, Gatenby RA, Kaznatcheev A, Jeavons P, Krishnan N, Pelesko J, Wadhwa RR, Yoon N, Nichol D, Marusyk A, Hinczewski M, Scott JG.

Phys Biol. 2019 Jun 19;16(4):041005. doi: 10.1088/1478-3975/ab1a09.

PMID:
30991381
4.

Automatic 3D Nonlinear Registration of Mass Spectrometry Imaging and Magnetic Resonance Imaging Data.

Abdelmoula WM, Regan MS, Lopez BGC, Randall EC, Lawler S, Mladek AC, Nowicki MO, Marin BM, Agar JN, Swanson KR, Kapur T, Sarkaria JN, Wells W, Agar NYR.

Anal Chem. 2019 May 7;91(9):6206-6216. doi: 10.1021/acs.analchem.9b00854. Epub 2019 Apr 22.

PMID:
30932478
5.

Multiparameter MRI Predictors of Long-Term Survival in Glioblastoma Multiforme.

Stringfield O, Arrington JA, Johnston SK, Rognin NG, Peeri NC, Balagurunathan Y, Jackson PR, Clark-Swanson KR, Swanson KR, Egan KM, Gatenby RA, Raghunand N.

Tomography. 2019 Mar;5(1):135-144. doi: 10.18383/j.tom.2018.00052.

6.

Accurate Patient-Specific Machine Learning Models of Glioblastoma Invasion Using Transfer Learning.

Hu LS, Yoon H, Eschbacher JM, Baxter LC, Dueck AC, Nespodzany A, Smith KA, Nakaji P, Xu Y, Wang L, Karis JP, Hawkins-Daarud AJ, Singleton KW, Jackson PR, Anderies BJ, Bendok BR, Zimmerman RS, Quarles C, Porter-Umphrey AB, Mrugala MM, Sharma A, Hoxworth JM, Sattur MG, Sanai N, Koulemberis PE, Krishna C, Mitchell JR, Wu T, Tran NL, Swanson KR, Li J.

AJNR Am J Neuroradiol. 2019 Mar;40(3):418-425. doi: 10.3174/ajnr.A5981. Epub 2019 Feb 28.

PMID:
30819771
7.

Lesion Dynamics Under Varying Paracrine PDGF Signaling in Brain Tissue.

Massey SC, Hawkins-Daarud A, Gallaher J, Anderson ARA, Canoll P, Swanson KR.

Bull Math Biol. 2019 Jun;81(6):1645-1664. doi: 10.1007/s11538-019-00587-z. Epub 2019 Feb 22.

PMID:
30796683
8.

Quantifying Uncertainty and Robustness in a Biomathematical Model-Based Patient-Specific Response Metric for Glioblastoma.

Hawkins-Daarud A, Johnston SK, Swanson KR.

JCO Clin Cancer Inform. 2019 Feb;3:1-8. doi: 10.1200/CCI.18.00066.

9.

Distinct Phenotypic Clusters of Glioblastoma Growth and Response Kinetics Predict Survival.

Rayfield CA, Grady F, De Leon G, Rockne R, Carrasco E, Jackson P, Vora M, Johnston SK, Hawkins-Daarud A, Clark-Swanson KR, Whitmire S, Gamez ME, Porter A, Hu L, Gonzalez-Cuyar L, Bendok B, Vora S, Swanson KR.

JCO Clin Cancer Inform. 2018 Dec;2:1-14. doi: 10.1200/CCI.17.00080.

10.

Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data.

Yang W, Warrington NM, Taylor SJ, Whitmire P, Carrasco E, Singleton KW, Wu N, Lathia JD, Berens ME, Kim AH, Barnholtz-Sloan JS, Swanson KR, Luo J, Rubin JB.

Sci Transl Med. 2019 Jan 2;11(473). pii: eaao5253. doi: 10.1126/scitranslmed.aao5253.

11.

Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma.

Randall EC, Emdal KB, Laramy JK, Kim M, Roos A, Calligaris D, Regan MS, Gupta SK, Mladek AC, Carlson BL, Johnson AJ, Lu FK, Xie XS, Joughin BA, Reddy RJ, Peng S, Abdelmoula WM, Jackson PR, Kolluri A, Kellersberger KA, Agar JN, Lauffenburger DA, Swanson KR, Tran NL, Elmquist WF, White FM, Sarkaria JN, Agar NYR.

Nat Commun. 2018 Nov 21;9(1):4904. doi: 10.1038/s41467-018-07334-3.

12.

Comparative dynamics of microglial and glioma cell motility at the infiltrative margin of brain tumours.

Juliano J, Gil O, Hawkins-Daarud A, Noticewala S, Rockne RC, Gallaher J, Massey SC, Sims PA, Anderson ARA, Swanson KR, Canoll P.

J R Soc Interface. 2018 Feb;15(139). pii: 20170582. doi: 10.1098/rsif.2017.0582.

13.

Mathematical model of perineural tumor spread: a pilot study.

Jacobs JJ, Capek S, Spinner RJ, Swanson KR.

Acta Neurochir (Wien). 2018 Mar;160(3):655-661. doi: 10.1007/s00701-017-3423-6. Epub 2017 Dec 21.

PMID:
29264779
14.

The biology and mathematical modelling of glioma invasion: a review.

Alfonso JCL, Talkenberger K, Seifert M, Klink B, Hawkins-Daarud A, Swanson KR, Hatzikirou H, Deutsch A.

J R Soc Interface. 2017 Nov;14(136). pii: 20170490. doi: 10.1098/rsif.2017.0490. Review.

15.

Letter: Surgical Decision Making From Image-Based Biophysical Modeling of Glioblastoma: Not Ready for Primetime.

Massey SC, Johnston SK, Canoll PD, Bruce JN, Bendok BR, Swanson KR.

Neurosurgery. 2018 Jan 1;82(1):E17-E18. doi: 10.1093/neuros/nyx481. No abstract available.

PMID:
29029349
16.

Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.

Sarkaria JN, Hu LS, Parney IF, Pafundi DH, Brinkmann DH, Laack NN, Giannini C, Burns TC, Kizilbash SH, Laramy JK, Swanson KR, Kaufmann TJ, Brown PD, Agar NYR, Galanis E, Buckner JC, Elmquist WF.

Neuro Oncol. 2018 Jan 22;20(2):184-191. doi: 10.1093/neuonc/nox175. Review.

17.

Simulating PDGF-Driven Glioma Growth and Invasion in an Anatomically Accurate Brain Domain.

Massey SC, Rockne RC, Hawkins-Daarud A, Gallaher J, Anderson ARA, Canoll P, Swanson KR.

Bull Math Biol. 2018 May;80(5):1292-1309. doi: 10.1007/s11538-017-0312-3. Epub 2017 Aug 25.

PMID:
28842831
18.

Awake Surgery for Brain Vascular Malformations and Moyamoya Disease.

Aoun RJN, Sattur MG, Krishna C, Gupta A, Welz ME, Nanney AD 3rd, Koht AH, Tate MC, Noe KH, Sirven JI, Anderies BJ, Bolton PB, Trentman TL, Zimmerman RS, Swanson KR, Bendok BR.

World Neurosurg. 2017 Sep;105:659-671. doi: 10.1016/j.wneu.2017.03.121. Epub 2017 Apr 2.

PMID:
28377246
19.

Defining the Immune Phenotype for Glioblastoma Multiforme: One Step Closer to Understanding Our Enemy.

Rahme RJ, Aoun RJ, Pines AR, Swanson KR, Bendok BR.

World Neurosurg. 2016 Nov;95:576-577. doi: 10.1016/j.wneu.2016.08.063. Epub 2016 Aug 23. No abstract available.

PMID:
27565464
20.

Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study.

Sonabend AM, Zacharia BE, Cloney MB, Sonabend A, Showers C, Ebiana V, Nazarian M, Swanson KR, Baldock A, Brem H, Bruce JN, Butler W, Cahill DP, Carter B, Orringer DA, Roberts DW, Sagher O, Sanai N, Schwartz TH, Silbergeld DL, Sisti MB, Thompson RC, Waziri AE, Ghogawala Z, McKhann G 2nd.

Neurosurgery. 2017 Apr 1;80(4):590-601. doi: 10.1227/NEU.0000000000001374. Erratum in: Neurosurgery. 2018 May 1;82(5):749.

21.

Radiogenomics to characterize regional genetic heterogeneity in glioblastoma.

Hu LS, Ning S, Eschbacher JM, Baxter LC, Gaw N, Ranjbar S, Plasencia J, Dueck AC, Peng S, Smith KA, Nakaji P, Karis JP, Quarles CC, Wu T, Loftus JC, Jenkins RB, Sicotte H, Kollmeyer TM, O'Neill BP, Elmquist W, Hoxworth JM, Frakes D, Sarkaria J, Swanson KR, Tran NL, Li J, Mitchell JR.

Neuro Oncol. 2017 Jan;19(1):128-137. doi: 10.1093/neuonc/now135. Epub 2016 Aug 8.

22.

War on Glioblastoma Multiforme: 2-Pronged Siege on Glutamine.

Panchanathan RS, Sittur MG, Aoun RJ, Pines AR, Swanson KR, Bendok BR.

World Neurosurg. 2016 Jul;91:254-6. doi: 10.1016/j.wneu.2016.04.074. Epub 2016 Apr 29. No abstract available.

PMID:
27133092
23.

Reply to comment on: 'Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach'.

Rockne R, Rockhill JK, Mrugala M, Spence AM, Kalet I, Hendrickson K, Lai A, Cloughesy T, Alvord EC, Swanson KR.

Phys Med Biol. 2016 Apr 7;61(7):2968-9. doi: 10.1088/0031-9155/61/7/2968. Epub 2016 Mar 17. No abstract available.

PMID:
26988701
24.

Multi-Parametric MRI and Texture Analysis to Visualize Spatial Histologic Heterogeneity and Tumor Extent in Glioblastoma.

Hu LS, Ning S, Eschbacher JM, Gaw N, Dueck AC, Smith KA, Nakaji P, Plasencia J, Ranjbar S, Price SJ, Tran N, Loftus J, Jenkins R, O'Neill BP, Elmquist W, Baxter LC, Gao F, Frakes D, Karis JP, Zwart C, Swanson KR, Sarkaria J, Wu T, Mitchell JR, Li J.

PLoS One. 2015 Nov 24;10(11):e0141506. doi: 10.1371/journal.pone.0141506. eCollection 2015.

25.

Addendum to 'A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET'.

Rockne RC, Trister AD, Jacobs J, Hawkins-Daarud AJ, Neal ML, Hendrickson K, Mrugala MM, Rockhill JK, Kinahan P, Krohn KA, Swanson KR.

J R Soc Interface. 2015 Nov 6;12(112). pii: 20150927. doi: 10.1098/rsif.2015.0927. No abstract available.

PMID:
26577597
Free PMC Article
26.

In silico analysis suggests differential response to bevacizumab and radiation combination therapy in newly diagnosed glioblastoma.

Hawkins-Daarud A, Rockne R, Corwin D, Anderson AR, Kinahan P, Swanson KR.

J R Soc Interface. 2015 Aug 6;12(109):20150388. doi: 10.1098/rsif.2015.0388.

27.

Patient-specific mathematical neuro-oncology: using a simple proliferation and invasion tumor model to inform clinical practice.

Jackson PR, Juliano J, Hawkins-Daarud A, Rockne RC, Swanson KR.

Bull Math Biol. 2015 May;77(5):846-56. doi: 10.1007/s11538-015-0067-7. Epub 2015 Mar 21. Review.

28.

Improvements in Correctional HIV Services: A Case Study in Delaware.

Swan H, O'Connell DJ, Visher CA, Martin SS, Swanson KR, Hernandez K.

J Correct Health Care. 2015 Apr;21(2):164-76. doi: 10.1177/1078345815574572.

29.

A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET.

Rockne RC, Trister AD, Jacobs J, Hawkins-Daarud AJ, Neal ML, Hendrickson K, Mrugala MM, Rockhill JK, Kinahan P, Krohn KA, Swanson KR.

J R Soc Interface. 2015 Feb 6;12(103). pii: 20141174. doi: 10.1098/rsif.2014.1174. Erratum in: J R Soc Interface. 2015 Nov 6;12(112). pii: 20150927. doi: 10.1098/rsif.2015.0927.

30.

Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction.

Morshed RA, Gutova M, Juliano J, Barish ME, Hawkins-Daarud A, Oganesyan D, Vazgen K, Yang T, Annala A, Ahmed AU, Aboody KS, Swanson KR, Moats RA, Lesniak MS.

Cancer Gene Ther. 2015 Jan;22(1):55-61. doi: 10.1038/cgt.2014.72. Epub 2014 Dec 19.

31.

Precision medicine in brain arteriovenous malformation management: arteries steal the show but veins may hold the crystal ball.

Zammar SG, Hamade YJ, Aoun RJ, El Tecle NE, El Ahmadieh TY, Lall RR, Taub ZD, Swanson KR, Chandler JP, Bendok BR.

Neurosurgery. 2014 Dec;75(6):N13-4. doi: 10.1227/01.neu.0000457193.02158.c9. No abstract available.

PMID:
25406620
32.

Response to "Tumor cells in search for glutamate: an alternative explanation for increased invasiveness of IDH1 mutant gliomas".

Trister A, Scott J, Rockne R, Yagle K, Johnston SK, Hawkins-Daarud A, Baldock A, Swanson KR.

Neuro Oncol. 2014 Dec;16(12):1670-1. doi: 10.1093/neuonc/nou290. No abstract available.

33.

Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomas.

Baldock AL, Ahn S, Rockne R, Johnston S, Neal M, Corwin D, Clark-Swanson K, Sterin G, Trister AD, Malone H, Ebiana V, Sonabend AM, Mrugala M, Rockhill JK, Silbergeld DL, Lai A, Cloughesy T, McKhann GM 2nd, Bruce JN, Rostomily RC, Canoll P, Swanson KR.

PLoS One. 2014 Oct 28;9(10):e99057. doi: 10.1371/journal.pone.0099057. eCollection 2014.

34.

Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients.

Adair JE, Johnston SK, Mrugala MM, Beard BC, Guyman LA, Baldock AL, Bridge CA, Hawkins-Daarud A, Gori JL, Born DE, Gonzalez-Cuyar LF, Silbergeld DL, Rockne RC, Storer BE, Rockhill JK, Swanson KR, Kiem HP.

J Clin Invest. 2014 Sep;124(9):4082-92. doi: 10.1172/JCI76739. Epub 2014 Aug 8.

35.

Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.

Smith TR, Lall RR, Lall RR, Abecassis IJ, Arnaout OM, Marymont MH, Swanson KR, Chandler JP.

J Neurosurg. 2014 Oct;121(4):839-45. doi: 10.3171/2014.4.JNS13789. Epub 2014 May 23.

PMID:
24857242
36.

Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status.

Baldock AL, Yagle K, Born DE, Ahn S, Trister AD, Neal M, Johnston SK, Bridge CA, Basanta D, Scott J, Malone H, Sonabend AM, Canoll P, Mrugala MM, Rockhill JK, Rockne RC, Swanson KR.

Neuro Oncol. 2014 Jun;16(6):779-86. doi: 10.1093/neuonc/nou027.

37.

Biomechanical comparison of two implants for the stabilization of incomplete ossification of the humeral condyle lesions in dogs.

Coggeshall JD, Lewis DD, Fitzpatrick N, Conrad BP, Swanson KR, Kim SE, Tremolada G, Pozzi A.

Vet Surg. 2014 Jan;43(1):58-65.

PMID:
24527494
38.

Toward patient-specific, biologically optimized radiation therapy plans for the treatment of glioblastoma.

Corwin D, Holdsworth C, Rockne RC, Trister AD, Mrugala MM, Rockhill JK, Stewart RD, Phillips M, Swanson KR.

PLoS One. 2013 Nov 12;8(11):e79115. doi: 10.1371/journal.pone.0079115. eCollection 2013.

39.

Modeling Tumor-Associated Edema in Gliomas during Anti-Angiogenic Therapy and Its Impact on Imageable Tumor.

Hawkins-Daarud A, Rockne RC, Anderson AR, Swanson KR.

Front Oncol. 2013 Apr 4;3:66. doi: 10.3389/fonc.2013.00066. eCollection 2013.

40.

From patient-specific mathematical neuro-oncology to precision medicine.

Baldock AL, Rockne RC, Boone AD, Neal ML, Hawkins-Daarud A, Corwin DM, Bridge CA, Guyman LA, Trister AD, Mrugala MM, Rockhill JK, Swanson KR.

Front Oncol. 2013 Apr 2;3:62. doi: 10.3389/fonc.2013.00062. eCollection 2013.

41.

Response classification based on a minimal model of glioblastoma growth is prognostic for clinical outcomes and distinguishes progression from pseudoprogression.

Neal ML, Trister AD, Ahn S, Baldock A, Bridge CA, Guyman L, Lange J, Sodt R, Cloke T, Lai A, Cloughesy TF, Mrugala MM, Rockhill JK, Rockne RC, Swanson KR.

Cancer Res. 2013 May 15;73(10):2976-86. doi: 10.1158/0008-5472.CAN-12-3588. Epub 2013 Feb 11.

42.

Discriminating survival outcomes in patients with glioblastoma using a simulation-based, patient-specific response metric.

Neal ML, Trister AD, Cloke T, Sodt R, Ahn S, Baldock AL, Bridge CA, Lai A, Cloughesy TF, Mrugala MM, Rockhill JK, Rockne RC, Swanson KR.

PLoS One. 2013;8(1):e51951. doi: 10.1371/journal.pone.0051951. Epub 2013 Jan 23.

43.

Adaptive IMRT using a multiobjective evolutionary algorithm integrated with a diffusion-invasion model of glioblastoma.

Holdsworth CH, Corwin D, Stewart RD, Rockne R, Trister AD, Swanson KR, Phillips M.

Phys Med Biol. 2012 Dec 21;57(24):8271-83. doi: 10.1088/0031-9155/57/24/8271. Epub 2012 Nov 29.

44.

Glial progenitor cell recruitment drives aggressive glioma growth: mathematical and experimental modelling.

Massey SC, Assanah MC, Lopez KA, Canoll P, Swanson KR.

J R Soc Interface. 2012 Aug 7;9(73):1757-66. doi: 10.1098/rsif.2012.0030. Epub 2012 Feb 7.

45.

Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens.

Ivkovic S, Beadle C, Noticewala S, Massey SC, Swanson KR, Toro LN, Bresnick AR, Canoll P, Rosenfeld SS.

Mol Biol Cell. 2012 Feb;23(4):533-42. doi: 10.1091/mbc.E11-01-0039. Epub 2012 Jan 4.

46.

Increased re-entry into cell cycle mitigates age-related neurogenic decline in the murine subventricular zone.

Stoll EA, Habibi BA, Mikheev AM, Lasiene J, Massey SC, Swanson KR, Rostomily RC, Horner PJ.

Stem Cells. 2011 Dec;29(12):2005-17. doi: 10.1002/stem.747.

47.

Quantifying the role of angiogenesis in malignant progression of gliomas: in silico modeling integrates imaging and histology.

Swanson KR, Rockne RC, Claridge J, Chaplain MA, Alvord EC Jr, Anderson AR.

Cancer Res. 2011 Dec 15;71(24):7366-75. doi: 10.1158/0008-5472.CAN-11-1399. Epub 2011 Sep 7.

48.

Production of 2-hydroxyglutarate by isocitrate dehydrogenase 1-mutated gliomas: an evolutionary alternative to the Warburg shift?

Scott JG, Basanta D, Chinnaiyan P, Canoll P, Swanson KR, Anderson AR.

Neuro Oncol. 2011 Dec;13(12):1262-4. doi: 10.1093/neuonc/nor083. Epub 2011 Jul 22. No abstract available.

49.

Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images.

Gu S, Chakraborty G, Champley K, Alessio AM, Claridge J, Rockne R, Muzi M, Krohn KA, Spence AM, Alvord EC Jr, Anderson AR, Kinahan PE, Swanson KR.

Math Med Biol. 2012 Mar;29(1):31-48. doi: 10.1093/imammb/dqr002. Epub 2011 May 11.

50.

The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view.

Basanta D, Scott JG, Rockne R, Swanson KR, Anderson AR.

Phys Biol. 2011 Feb;8(1):015016. doi: 10.1088/1478-3975/8/1/015016. Epub 2011 Feb 7.

Supplemental Content

Loading ...
Support Center